TG2-induced NF-kB activation promotes the EMT–CSC phenotype in tumour cells, and TGF-β exhibited a complete dependency on TG2 for its capability for inducing EMT in breast cancer cells [35]. This evidence concerns the gene TGM2 and neoplasm.